Helping Young People With Testicular Cancer Using Virtual and Extended Reality

Exclusion criteria

• . Non-testicular germ cell tumours (e.g., mediastinal primary or retroperitoneal primary tumours).
• . Non-germ cell TC.
• . Previous chemotherapy, radiotherapy, or surgery for TC other than that allowed in IC 4.
• . History of contralateral TC.
• . Any illness that would prevent the AYA TC survivor from giving a valid and signed informed consent, as assessed by the investigator.
• . Any illness that might be exacerbated by the use of an XR digital tool, as assessed by the investigator, including history of severe motion sickness, brain lesions and epilepsy.
• . Uncontrolled medical condition such as uncontrolled infection, uncontrolled diabetes mellitus or cardiac disease (including but not limited to grade 2 or higher cardiac failure, arrythmia, unstable angina, history of myocardial infract in the 6 months which, in the opinion of the treating physician, would influence the assessment of long-term side effect of TC treatment.
• . AYA TC survivors with a "currently active" second malignancy other than non-melanoma skin cancers, superficial non-invasive (pTa or pTis) TCC of the bladder, or intratubular germ cell neoplasia. Patients are not considered to have a "currently active" malignancy if they have completed therapy and are free of disease for ≥ 3 years.